Edited by Dentaltown staff
TORONTO—Oravital, the manufacturer of the Oravital System for the diagnosis and treatment of periodontal disease and halitosis, will be making its debut at the Chicago Midwinter Dental Meeting at booth #4537 from February 25th through February 27th.
During this time, the company will also unveil its latest weapon in the war against oral infections—the BiofilmDNA oral microbial salivary test.
BiofilmDNA is a highly-sensitive DNA test that detects both the presence and thresholds of specific pathogens via the collection of salivary, subgingival, and tongue biofilm samples. This advanced and accurate biofilm analysis provides the dental clinician with a detailed, multi-panel, whole-mouth picture of the patient’s oral health.
Oravital’s new BiofilmDNA test complements its BiofilmGS test, which uses site-specific Gram stain analysis to determine the exact type and location of oral infection. Both the BiofilmDNA and BiofilmGS tests are analyzed in Oravital’s on-site lab facility, with reports available within two days of receiving the samples. Used together, the two biofilm tests will help the dental clinician accurately identify periodontal disease pathogens, opportunistic parasites, caries pathogens, yeasts, and inflammatory response.
“The Oravital System effectively closes the diagnosis/treatment loop by identifying the exact cause and location of oral infection, then providing a highly-effective regimen of antibiotic and antimicrobial rinses specifically prescribed for the patient’s personal diagnosis," said company president and CEO Dr. Jim Hyland.
Dr. Hyland, DDS BSc, and his clinical management team consisting of Chief Science Officer Anne Bosy, RRDH, MEd, MSc, and Clinical Hygiene Educator Kerry Lepicek, RDH, will be on hand to explain the efficacy and application of the proprietary Oravital System, which consists of the following five steps: diagnosis, treatment, evaluation, maintenance and monitoring.
“Undiagnosed and untreated oral infections are a North American epidemic,” said Hyland. “We also know that periodontal disease is a contributing factor to many systemic conditions such as cardiovascular disease, diabetes, and Alzheimer’s disease, because the infection spreads via both tissues and the blood stream. With the introduction of BiofilmDNA®, now more than ever, the Oravital® system can have a positive impact on not just the oral health, but the overall health of the patient.”
For more information on the Oravital System and how your dental practice can become a Certified Oravital Clinic, visit Oravital.com or call (800) 909-6468.